Register Financial Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Register Financial Advisors's PFE Position: Q3 2026 in Review
Register Financial Advisors reduced its Pfizer (PFE) stake by 11% in Q3 2026, selling an estimated $134K and leaving 39,109 shares worth $1.12M. The position accounts for 0.35% of the portfolio, ranked #79.
Register Financial Advisors first reported a position in PFE in Q4 2022 and has held it in 16 quarters since. The position peaked at $1.77M in Q3 2024. 1,831 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Register Financial Advisors held 39,109 shares of Pfizer worth $1.12M as of Q3 2026.
- Register Financial Advisors sold 5,024 Pfizer shares in Q3 2026, an estimated $134K.
- Pfizer made up 0.35% of Register Financial Advisors's portfolio in Q3 2026, its #79 holding.
- Register Financial Advisors first reported a position in Pfizer in Q4 2022 and has held it in 16 quarters since.
- Register Financial Advisors's Pfizer position peaked at $1.77M in Q3 2024.
- 1,831 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Register Financial Advisors's 13F filing for Q3 2026, filed 23 Oct 2026.